Quantitative coronary angiographic studies of patients with angina pectoris and impaired glucose tolerance

Diabetes Care

Volumn 28, Issue 9, 2005, Pages 2217-2222

  Kataoka, Yu ^a   Yasuda, Satoshi ^a   Morii, Isao ^a   Otsuka, Yoritaka ^a   Kawamura, Atsushi ^a   Miyazaki, Shunichi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL DIAMETER; COMPUTER ASSISTED DIAGNOSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS;

AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; BODY MASS INDEX; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RETROSPECTIVE STUDIES; VASCULAR DISEASES;

EID: 24144445420     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.9.2217     Document Type: Article

References (29)

1. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 22:920-924, 1999
2. The DECODE study group, the European Diabetes Epidemiology Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397-404, 2001
3. Natali A, Vichi S, Landi P, Seven S, L'Abbate A, Ferrannini E: Coronary atherosclerosis in type II diabetes: angiographic findings and clinical outcome. Diabetologia 43:632-641, 2000
4. Vigorita VJ, Moore GW, Hutchins GM: Absence of correlation between coronary arterial atherosclerosis and severity or duration of diabetes mellitus of adult onset. Am J Cardiol 46:535-542, 1980
5. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
6. Gensini GG: Coronary Angiography. Mount Kisco, NY, Futura, 1975
7. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140-2144, 2002
8. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A, Eschwege E: High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21:360-365, 1998
9. Laakso M, Lehto SI: Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis 137:565-573, 1998
10. Harris MI: Impaired glucose tolerance: prevalence and conversion to NIDDM. Diabet Med 13:540-545, 1996
11. Baron AD: Impaired glucose tolerance as a disease. Am J Cardiol 88 (Suppl. 6A):16H-19H, 2001
12. Seibaek M, Sloth C, Vallebo L, Hansen T, Urhammer SA Burchardt H, Torp-Pedersen C, Pedersen O, Hildebrandt P: Glucose tolerance status and severity of coronary artery disease in men referred to coronary arteriography. Am Heart J 133: 622-629, 1997
13. Ledru F, Ducimetiere P, Battaglia S, Courbon D Beverelli F, Guize L, Guermonprez JL, Diebold B: New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. J Am Coll Cardiol 37:1543-1550, 2001
14. Brown BG, Bolson F, Frimer M, Dodge HT: Quantitative coronary angiography: estimation of dimensions, hemodynamic resistance and atheroma mass of coronary lesions using the arteriogram and digital computation. Circulation 55:329-335, 1977
15. Mancini JGB: Quantitative coronary arteriography: Development of methods, limitations and clinical applications. Am J Cardiac Imaging 2:98-109, 1988
16. Reiber JH, Kooijman CJ, Slager CJ, Gerbrands JJ, Schuurbiers JCH, Boer AD, Wijns W, Serruys PW, Hugenholtz PG: Coronary artery dimension from cineangiograms: methodology and validation of a computer assisted analysis procedure. IEEE Trans Med Imaging MI-3:131-141, 1984
17. Hanekamp C, Koolen J, Bonnier H, Oldroyd K, de Boer MJ, Heublein B, Visser C, Small Vessel Study Group: Randomized comparison of balloon angioplasty versus silicon carbon-coated stent implantation for de novo lesions in small coronary arteries. Am J Cardiol 93:1233-1237, 2004
18. Schampaert E, Cohen EA, Schluter M, Reeves F, Traboulsi M, Title LM Kuntz RE, Popma JJ, C-SIRIUS investigators: The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43: 1110-1115, 2004
19. Kerelakes DJ: Coronary small-vessel stenting in the era of drug elution. Rev Cardiovasc Med 5 (Suppl. 2):S34-S45, 2004
20. Di Sciascio G, Patti G, Nasso G, Manzoli A, D'Ambrosio A, Abbate A: Early and long-term results of stenting of diffuse coronary artery disease. Am J Cardiol 86: 1166-1170, 2000
21. Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Holmes DR Jr: Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the prevention of restenosis with tranilast and its outcomes (PRESTO) trial. Circulation 109: 2727-2731, 2004
22. Ross MJ, Herrmann HC, Moliterno DJ, Blankenship JC, Demopoulos L, DiBattiste PM, Ellis SG, Ghazzal Z, Martin JL, White J, Topol EJ: Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibitors: results from the TARGET trial. J Am Coll Cardiol 42:981-988, 2003
23. Brownlee M: Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46:223-234, 1995
24. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform β2 and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A 89:11059-22063, 1992
25. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
26. Haffner SM: The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. Endocr Rev 19:583-592, 1998
27. de Vegt F, Dekker JM, Ruhe HG, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ: Hyperglycemia is associated with all cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926-931, 1999
28. Harold EL: Effect of the postprandial state on nontraditional risk factors. Am J Cardiol 88 (Suppl. 6A):20H-25H, 2001
29. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Qotola M, Quagliaro L, Ceriello A, Giugliano D: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-2072, 2002